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Human influenza A viruses cause epidemics and pandemics (<http://www.who.int/topics/influenza/en/>). The most recent influenza pandemic and the epidemics following it were associated with influenza A(H1N1)pdm09 viruses. Infections with these viruses in most cases were self-limiting and led to the recovery of infected individuals within 1 week. However, in some cases, infections with A(H1N1)pdm09 viruses resulted in hospitalizations. Many different factors might be associated with the hospitalization of patients infected with A(H1N1)pdm09 viruses, including viral and host genetics, underlying health conditions, and lifestyle and environmental factors.

In this study, we searched for viral genetic factors that might be associated with patient hospitalizations. In particular, we sequenced the whole genomes of 40 influenza A(H1N1)pdm09 strains isolated from nonhospitalized and hospitalized patients (Finland, 2009 to 2014) who were diagnosed with influenza A virus infection. The sequencing procedure is described elsewhere ([@B1]). We analyzed the resulting sequences together with 186 other sequences of influenza strains isolated during the same period in Finland ([@B1][@B2][@B4]). A comparative analysis of whole-genome sequences of influenza strains isolated from 56 hospitalized and 170 nonhospitalized Finnish patients revealed 29 missense mutations that might be associated with patient hospitalizations (*P* \< 0.00005, chi-square test of independence). Ten mutations were found in viral hemagglutinin (HA) (D114N, S202T, E391K, S468N and E516K; numbering is based on the mature HA protein with the signal sequence) and neuraminidase (NA) (N44S, I106V, N200S, V241I, and N369K) glycoproteins. Thirteen signatures were found in polymerase subunits polymerase acidic (PA) (N321K), polymerase basic 1 (PB1) (G154D, I397M, I435T, and V525I), and PB2 (R54K, M66I, D195N, R293K, N340K, V344M, I354L, and V731I). Two signatures were found in matrix 1 (M1) (V80I and K230I), one in M2 (D21G), one in nonstructural 1 (NS1) (L90I), one in nucleoprotein (NP) (S498N), and one in PA-X (R221Q). No signatures were found in NS2/NEP.

Interestingly, 12 of the 29 mutations were previously identified. In particular, mutations at positions 114/97, 202/185, 391/374, and 468/451 of HA (numbering is based on the mature HA protein with/without the signal sequence), 106, 241, and 369 of NA, 321 of PA, 344 and 354 of PB2, 80 of M1, and their combinations were shown to enhance virus replication in human cells and mice and contribute to an increased severity of A(H1N1)pdm09 virus infections in patients admitted to hospitals in England during 2009 to 2011 ([@B5]). Mutations at positions 340 of PB2 and 106 of NA were associated previously with influenza virus virulence in humans and mice ([@B6][@B7][@B8]). We were unable to detect the D222G mutation in HA (numbering is based on the mature HA protein lacking the signal sequence), which was proposed to contribute to the severity of the disease ([@B9]). In contrast, we observed that this mutation (N/D239G in full-length HA with signal peptide) was associated with virus propagation in MDCK cell culture ([@B9]). Thus, we validated 12 known and identified 17 novel viral factors that are potentially associated with patient hospitalization.

We found that the viruses that circulated in 2013/2014 in Finland drifted from the earliest Finnish A(H1N1)pdm09 isolate (A/Helsinki/P15/2009), for which the whole-genome sequence is available, by ca. 1.3% at the amino acid level. This indicates that novel mutations associated with patient hospitalizations may emerge and should therefore be monitored.
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The full-genome sequences of influenza A viruses have been deposited in GenBank under the accession numbers [KM437818](KM437818) to [KM437825](KM437825), [KM437826](KM437826) to [KM437833](KM437833), [KM437770](KM437770) to [KM437777](KM437777), [KM437778](KM437778) to [KM437785](KM437785), [KM437706](KM437706) to [KM437713](KM437713), [KM437842](KM437842) to [KM437849](KM437849), [KM437786](KM437786) to [KM437793](KM437793), [KM437794](KM437794) to [KM437801](KM437801), [KM437682](KM437682) to [KM437689](KM437689), [KM437658](KM437658) to [KM437665](KM437665), [KM437666](KM437666) to [KM437673](KM437673), [KM437674](KM437674) to [KM437681](KM437681), [KM437690](KM437690) to [KM437697](KM437697), [KM437698](KM437698) to [KM437705](KM437705), [KM437722](KM437722) to [KM437729](KM437729), [KM366559](KM366559) to [KM366566](KM366566), [KM366351](KM366351) to [KM366358](KM366358), [KM366359](KM366359) to [KM366366](KM366366), [KM366367](KM366367) to [KM366374](KM366374), [KM366391](KM366391) to [KM366398](KM366398), [KM366399](KM366399) to [KM366406](KM366406), [KM366407](KM366407) to [KM366414](KM366414), [KM366415](KM366415) to [KM366422](KM366422), [KM366423](KM366423) to [KM366430](KM366430), [KM366431](KM366431) to [KM366438](KM366438), [KM366439](KM366439) to [KM366446](KM366446), [KM366447](KM366447) to [KM366454](KM366454), [KM366463](KM366463) to [KM366470](KM366470), [KM366479](KM366479) to [KM366486](KM366486), [KM366487](KM366487) to [KM366494](KM366494), [KM366495](KM366495) to [KM366502](KM366502), [KM366503](KM366503) to [KM366510](KM366510), [KM366511](KM366511) to [KM366518](KM366518), [KM366519](KM366519) to [KM366526](KM366526), [KM366527](KM366527) to [KM366534](KM366534), [KM366543](KM366543) to [KM366550](KM366550), [KM366551](KM366551) to [KM366558](KM366558), [KM366567](KM366567) to [KM366574](KM366574), [KM366575](KM366575) to [KM366582](KM366582), and [KM366383](KM366383) to [KM366390](KM366390).
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